Target intelligence / Profile preview

Murine norovirus replication machinery

Molecular classification
Viral replication complex, Enzyme, RNA-dependent RNA polymerase, Cysteine protease, Other
01

Overview

The Murine norovirus (MNV) replication machinery is a multi-protein complex essential for the life cycle of MNV, a member of the Caliciviridae family (Thorne and Goodfellow, 2014). This machinery is primarily composed of seven non-structural proteins (NS1-NS7) encoded by the viral Open Reading Frame 1 (ORF1). Key enzymatic activities within this complex include the NS6 protease, which is responsible for the proteolytic processing of the viral polyprotein, and the NS7 RNA-dependent RNA polymerase (RdRp), which facilitates the replication of the positive-sense RNA genome (Arias et al., 2012). Because MNV can be efficiently grown in cell culture and shares significant structural and functional homology with human noroviruses, it serves as the gold-standard surrogate model for studying norovirus replication and testing potential therapeutics (Wobus et al., 2006). Antiviral strategies targeting this machinery often focus on nucleoside analogs that cause chain termination or lethal mutagenesis during RNA synthesis, as well as small-molecule inhibitors that block protease activity (Rocha-Pereira et al., 2014). Inhibiting these components effectively prevents the production of new viral progeny, making the replication machinery a high-priority target for treating norovirus-induced gastroenteritis.

Other names
Murine norovirus replication complexMNV replication complexMNV non-structural proteinsMNV NS proteinsMNV ORF1 polyproteinMurine norovirus RNA-dependent RNA polymeraseMurine norovirus protease
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase (RdRp) activity, induction of lethal mutagenesis, or inhibition of the viral NS6 protease to prevent polyprotein cleavage.

03

Biological functions

Viral replicationRNA synthesisPolyprotein processingViral genome replicationOther
04

Disease associations

InfectionOther
05

Safety considerations

Potential for host cell mitochondrial toxicity with nucleoside analogsRapid emergence of viral resistance mutationsOff-target inhibition of host RNA polymerases
06

Interacting drugs

Ribavirin

4 more in the full profile.

07

Biomarkers

Viral RNA titerViral plaque-forming units (PFU)NS7 polymerase activity levels

Beyond the preview

Go deeper on Murine norovirus replication machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Murine norovirus replication machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call